Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Pescador, Nuria ^a,b   Pérez Barba, Milagros ^b   Ibarra, José María ^a,b   Corbatón, Arturo ^a,b   Martínez Larrad, María Teresa ^a,b   Serrano Ríos, Manuel ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 138; MICRORNA 15B; MICRORNA 376A; MICRORNA 503; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEREGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA FINGERPRINTING;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84885448790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077251     Document Type: Article

References (34)

1. Aranceta Bartrina J, (2002) Prevalence of obesity in developed countries: current status and perspectives. Nutr Hosp. 17(1):: 34-41. PubMed: 11939127.
2. Permana PA, Del Parigi A, Tataranni PA, (2004) Microarray gene expression profiling in obesity and insulin resistance. Nutrition. 20(1):: 134-138. doi:10.1016/j.nut.2003.09.023. PubMed: 14698028.
3. Kussmann M, Raymond F, Affolter M, (2006) OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 124(4):: 758-787. doi:10.1016/j.jbiotec.2006.02.014. PubMed: 16600411.
4. Schmid C, Goede DL, Hauser RS, Brändle M, (2006) Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss Med Wkly 136(15-16):: 254-258. PubMed: 16708311.
5. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell. 11: 441-450. doi:10.1016/j.devcel.2006.09.009. PubMed: 17011485.
6. Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ, (2011) Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab 96: E846-E850. doi:10.1210/jc.2010-2701. PubMed: 21367929.
7. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, et al. (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474: 649-653. doi:10.1038/nature10112. PubMed: 21654750.
8. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, et al. (2010) Plasma microrna profiling reveals loss of endothelial mir-126 and other micrornas in type 2 diabetes. Circ Res 107: 810-817. doi:10.1161/CIRCRESAHA.110.226357. PubMed: 20651284.
9. Kong L, Zhu J, Han W, Jiang X, Xu M, et al. (2011) Significance of serum micrornas in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study. Acta Diabetolol. 48: 61-9.
10. Pandey AK, Agarwal P, Kaur K, Datta M, (2009) Micrornas in diabetes:Tiny players in big disease. Cell Physiol Biochem 23: 221-232. doi:10.1159/000218169. PubMed: 19471090.
11. Ortega FJ, Mercader JM, Catalán V, Moreno-Navarrete JM, Pueyo N, et al. (May(2013) Targeting the Circulating MicroRNA Signature of Obesity. Clin Chem May; 59(5):: 781-792. doi:10.1373/clinchem.2012.195776. PubMed: 23396142.
12. Müller G, (2010) Control of lipid storage and cell size between adipocytes by vesicle-associated glycosylphosphatidylinositol-anchored proteins. Arch Physiol Biochem117: 23-43. PubMed: 20883086.
13. Aoki N, Jin-no S, Nakagawa Y, et al. (2007) Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology.148: 3850-3862. doi:10.1210/en.2006-1479. PubMed: 17478559.
14. Record M, Subra C, Silvente-Poirot, Poirot M (2011) Exosomes as intracellular signalosomes and pharmacological effectors. Biochem Pharmacol; 81: 1171-1182. doi:10.1016/j.bcp.2011.02.011. PubMed: 21371441.
15. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol;3: RESEARCH0034. PubMed: 12184808.
16. Redell JB, Moore AN, Ward NH 3rd, Hergenroeder GW, Dash PK, (2010) Human traumatic brain injury alters plasma microRNA levels. J Neurotrauma 27: 2147-2156. doi:10.1089/neu.2010.1481. PubMed: 20883153.
17. Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, et al. (2013) Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med 7: 11:31. PubMed: 23391324.
18. Kaduthanam S, Gade S, Meister M, Brase JC, Johannes M, et al. (2013) Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer. 80(2):: 223-227. doi:10.1016/j.lungcan.2013.01.013. PubMed: 23410826.
19. Liu J, Mao Q, Liu Y, Hao X, Zhang S, et al. (2013) Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 25(1):: 46-54. PubMed: 23372341.
20. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell. Res18(10):: 997-1006. doi:10.1038/cr.2008.282. PubMed: 18766170.
21. Yang Z, Bian C, Zhou H, et al. (2011) MicroRNA hsa-miR-138 Inhibits Adipogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Through Adenovirus EID-1. Stem Cells Dev 20: 259-267. doi:10.1089/scd.2010.0072. PubMed: 20486779.
22. Rosen ED, MacDougald OA, (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896. doi:10.1038/nrm2066. PubMed: 17139329.
23. Joglekar MV, Parekh VS, Hardikar AA, (2007) New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol Metab 18(10):: 393-400. doi:10.1016/j.tem.2007.10.001. PubMed: 18023200.
24. Gu G, Dubauskaite J, Melton DA, (2002) Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development. 129(10):: 2447-2457. PubMed: 11973276.
25. Heremans Y, Van De Casteele M, in't Veld P, Gradwohl G, Serup P, et al. (2002) Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol 159(2):: 303-312. doi:10.1083/jcb.200203074. PubMed: 12403815.
26. Baeyens L, Bonné S, German MS, Ravassard P, Heimberg H, et al. (2006) Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway. Cell Death Differ 13(11):: 1892-1899. doi:10.1038/sj.cdd.4401883. PubMed: 16514419.
27. Mellitzer G, Martín M, Sidhoum-Jenny M, Orvain C, Barths J, et al. (2004) Pancreatic islet progenitor cells in neurogenin 3-yellow fluorescent protein knock-add-on mice. Mol Endocrinol 18(11):: 2765-2776. doi:10.1210/me.2004-0243. PubMed: 15297605.
28. Zhang Y, Cheng X, Lu Z, Wang J, Chen H, et al. (2013) Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease. Diabetes Res Clin Pract 99(3):: 327-334. doi:10.1016/j.diabres.2012.11.025. PubMed: 23287814.
29. Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP, (2007) Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 102(2):: 399-408. doi:10.1111/j.1572-0241.2006.01041.x. PubMed: 17311652.
30. Youssef WI, McCullough AJ, (2002) Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol 16(5):: 733-747. doi:10.1053/bega.2002.0334. PubMed: 12406442.
31. Zheng Y, Yin L, Chen H, Yang S, Pan C, et al. (2012) miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. FEBS Lett 30;586Volumes 16: 2396-2403 PubMed: 22684007.
32. Macias-Gonzalez M, Moreno-Santos I, García-Almeida JM, Tinahones FJ, Garcia-Fuentes E, (2009) PPARgamma2 protects against obesity by means of a mechanism that mediates insulin resistance. Eur J Clin Invest 39(11):: 972-979. doi:10.1111/j.1365-2362.2009.02198.x. PubMed: 19645740.
33. Rocha PM, Barata JT, Teixeira PJ, Ross R, Sardinha LB, (2008) Independent and opposite associations of hip and waist circumference with metabolic syndrome components and with inflammatory and atherothrombotic risk factors in overweight and obese women. Metabolism. 57(10):: 1315-1322. doi:10.1016/j.metabol.2008.01.003. PubMed: 18803932.
34. Gong H, Song L, Lin C, Liu A, Lin X, et al. (2013) Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin Cancer Res19(5):: 1083-1093. doi:10.1158/1078-0432.CCR-12-3169. PubMed: 23319823.